Ioannou Athanasia, Berkhout Maryse D, Geerlings Sharon Y, Belzer Clara
Laboratory of Microbiology, Wageningen University and Research, Wageningen, The Netherlands.
Nat Rev Microbiol. 2025 Mar;23(3):162-177. doi: 10.1038/s41579-024-01106-1. Epub 2024 Oct 15.
Akkermansia muciniphila is a gut bacterium that colonizes the gut mucosa, has a role in maintaining gut health and shows promise for potential therapeutic applications. The discovery of A. muciniphila as an important member of our gut microbiome, occupying an extraordinary niche in the human gut, has led to new hypotheses on gut health, beneficial microorganisms and host-microbiota interactions. This microorganism has established a unique position in human microbiome research, similar to its role in the gut ecosystem. Its unique traits in using mucin sugars and mechanisms of action that can modify host health have made A. muciniphila a subject of enormous attention from multiple research fields. A. muciniphila is becoming a model organism studied for its ability to modulate human health and gut microbiome structure, leading to commercial products, a genetic model and possible probiotic formulations. This Review provides an overview of A. muciniphila and Akkermansia genus phylogeny, ecophysiology and diversity. Furthermore, the Review discusses perspectives on ecology, strategies for harnessing beneficial effects of A. muciniphila for human mucosal metabolic and gut health, and its potential as a biomarker for diagnostics and prognostics.
嗜黏蛋白阿克曼氏菌是一种定殖于肠道黏膜的肠道细菌,在维持肠道健康方面发挥作用,并展现出潜在的治疗应用前景。嗜黏蛋白阿克曼氏菌作为我们肠道微生物群的重要成员被发现,在人类肠道中占据着特殊的生态位,这引发了关于肠道健康、有益微生物以及宿主-微生物群相互作用的新假说。这种微生物在人类微生物组研究中确立了独特地位,类似于其在肠道生态系统中的作用。它利用黏蛋白糖的独特特性以及能够改变宿主健康的作用机制,使得嗜黏蛋白阿克曼氏菌成为多个研究领域极为关注的对象。嗜黏蛋白阿克曼氏菌正成为一种模式生物,因其调节人类健康和肠道微生物组结构的能力而受到研究,这催生了商业产品、遗传模型以及可能的益生菌制剂。本综述概述了嗜黏蛋白阿克曼氏菌及阿克曼氏菌属的系统发育、生态生理学和多样性。此外,该综述还讨论了生态学观点、利用嗜黏蛋白阿克曼氏菌对人类黏膜代谢和肠道健康产生有益影响的策略,以及其作为诊断和预后生物标志物的潜力。